Developmental malformations resulting from high-dose maternal tamoxifen exposure in the mouse.
Tamoxifen is an estrogen receptor (ER) ligand with widespread use in clinical and basic research settings. Beyond its application in treating ER-positive cancer, tamoxifen has been co-opted into a powerful approach for temporal-specific genetic alteration. The use of tamoxifen-inducible Cre-recombin...
Saved in:
Main Authors: | Miranda R Sun, Austin C Steward, Emma A Sweet, Alexander A Martin, Robert J Lipinski |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/8b17ba8695694a41b57d7cab74fb038c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tamoxifen-independent recombination in the RIP-CreER mouse.
by: Yanmei Liu, et al.
Published: (2010) -
Tianeptine, but not fluoxetine, decreases avoidant behavior in a mouse model of early developmental exposure to fluoxetine
by: Elizabeth A. Pekarskaya, et al.
Published: (2021) -
CHD7 deficiency in "Looper", a new mouse model of CHARGE syndrome, results in ossicle malformation, otosclerosis and hearing impairment.
by: Jacqueline M Ogier, et al.
Published: (2014) -
Dose-dependent effects of Hedyotis diffusa extract on the pharmacokinetics of tamoxifen, 4-hydroxytamoxifen, and N-desmethyltamoxifen
by: Yung-Yi Cheng, et al.
Published: (2022) -
A mouse model of prenatal exposure to Interleukin-6 to study the developmental origin of health and disease
by: Tarak Srivastava, et al.
Published: (2021)